Drug Testing and Adherence Monitoring in Substance Abuse Patients
A Russian proverb was espoused by former president Ronald Regan in the 1980s in negotiations with the Soviet leadership, “Trust, but verify.” This same concept has been adopted by many physicians working with patients on chronic opioid therapy. Physicians that prescribe chronic opioid therapy have an ethical and legal responsibility to monitor for treatment adherence. One way to enhance the trust between the prescribing physician and the patient is to implement a comprehensive adherence-monitoring program.
KeywordsDrug testing Adherence monitoring Substance abuse Prescription drug monitoring programs Stratification of risk Pill counts An algorithmic approach
- 6.Centers for Disease Control and Prevention. CDC grand rounds: prescription drug overdoses—a U.S. epidemic. MMWR Morb Mortal Wkly Rep. 2012;61:10–3.Google Scholar
- 7.Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers—United States, 1999–2008. MMWR Morb Mortal Wkly Rep. 2011;60:1487–92.Google Scholar
- 9.Report of the International Narcotics Control Board for 2011. United Nations, New York; 2011. www.unodc.org/documents/southasia/reports/2011_INCB_ANNUAL_REPORT_english_PDF.pdf.
- 10.The Use of Medicines in the United States: review of 2011. Report by the IMS Institute for Healthcare Informatics. www.imshealth.com.
- 14.Centers for Disease Control and Prevention. Prescription drug overdose: state law. http://www.cdc.gov/HomeandRecreationalSafety/poisoning/laws/index.html.
- 20.Drug Enforcement Administration and the National Alliance for Model State Drug Laws. A closer look at state prescription monitoring programs. http://www.deadiversion.usdoj.gov/pubs/program/prescription-monitor/summary.htm.
- 26.Manchikanti L, Hirsch JA. The pains of chronic opioid usage [Spotlight]. AHRQ WebM&M [serial online]. September 2013.Google Scholar